Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts

Guffanti, F.; Alvisi, M F; Anastasia, A.; Ricci, F.; Chiappa, M.; Llop-Guevara, A.; Serra, V.; Fruscio, R.; Degasperi, A.; Nik-Zainal, S.; Bani, M R; Lupia, M.; Giavazzi, R.; Rulli, E.; Damia, G.

doi:10.1038/s41416-023-02205-1

Download PDF

Correction
Published: 16 February 2023

Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts

F. Guffanti¹,
M F Alvisi²,
A. Anastasia³,
F. Ricci¹,
M. Chiappa¹,
A. Llop-Guevara⁴,
V. Serra ORCID: orcid.org/0000-0001-6620-1065⁴,
R. Fruscio⁵,
A. Degasperi ORCID: orcid.org/0000-0001-6879-0596^6,7,
S. Nik-Zainal^6,7,
M R Bani³,
M. Lupia⁸,
R. Giavazzi³,
E. Rulli² &
…
G. Damia ORCID: orcid.org/0000-0001-9749-434X¹

British Journal of Cancer volume 128, page 1405 (2023)Cite this article

360 Accesses
1 Citations
1 Altmetric
Metrics details

Subjects

The Original Article was published on 03 November 2021

Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-021-01609-1, published online 03 November 2021

The original version of this article contained an affiliation error. Affiliation 8 affiliation states: “Unit of Gynecological Oncology Research, European Institute of Oncology, Milan, Italy” and needs to be changed to: “Unit of Gynecological Oncology Research, IEO, European Institute of Oncology IRCCS, Milan, Italy”. The original article has been corrected.

Author information

Authors and Affiliations

Laboratory of Molecular Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
F. Guffanti, F. Ricci, M. Chiappa & G. Damia
Laboratory of Methodology for Clinical Research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
M F Alvisi & E. Rulli
Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
A. Anastasia, M R Bani & R. Giavazzi
Experimental Therapeutics Group, Vall d’Hebron Institute of Oncology, Barcelona, Spain
A. Llop-Guevara & V. Serra
Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, San Gerardo Hospital, University of Milan Bicocca, Monza, Italy
R. Fruscio
MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK
A. Degasperi & S. Nik-Zainal
Academic Laboratory of Medical Genetics, Lv 6 Addenbrooke’s Treatment Centre, Addenbrooke’s Hospital, Box 238, Cambridge, CB2 0QQ, UK
A. Degasperi & S. Nik-Zainal
Unit of Gynecological Oncology Research, IEO, European Institute of Oncology IRCCS, Milan, Italy
M. Lupia

Authors

F. Guffanti
View author publications
You can also search for this author in PubMed Google Scholar
M F Alvisi
View author publications
You can also search for this author in PubMed Google Scholar
A. Anastasia
View author publications
You can also search for this author in PubMed Google Scholar
F. Ricci
View author publications
You can also search for this author in PubMed Google Scholar
M. Chiappa
View author publications
You can also search for this author in PubMed Google Scholar
A. Llop-Guevara
View author publications
You can also search for this author in PubMed Google Scholar
V. Serra
View author publications
You can also search for this author in PubMed Google Scholar
R. Fruscio
View author publications
You can also search for this author in PubMed Google Scholar
A. Degasperi
View author publications
You can also search for this author in PubMed Google Scholar
S. Nik-Zainal
View author publications
You can also search for this author in PubMed Google Scholar
M R Bani
View author publications
You can also search for this author in PubMed Google Scholar
M. Lupia
View author publications
You can also search for this author in PubMed Google Scholar
R. Giavazzi
View author publications
You can also search for this author in PubMed Google Scholar
E. Rulli
View author publications
You can also search for this author in PubMed Google Scholar
G. Damia
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Damia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guffanti, F., Alvisi, M.F., Anastasia, A. et al. Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts. Br J Cancer 128, 1405 (2023). https://doi.org/10.1038/s41416-023-02205-1

Download citation

Published: 16 February 2023
Issue Date: 30 March 2023
DOI: https://doi.org/10.1038/s41416-023-02205-1

Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts

Subjects

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Search

Quick links

Subjects

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Quick links